Pre-Market Review: Baxter, CareFusion, Unilife, and Mindray Medical
LONDON, July 1, 2013 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
On Friday, June 28, 2013, shares in medical device companies ended mostly lower as the broader market tumbled, with the S&P 500 and the Dow Jones finishing lower. The NASDAQ, on the other hand, closed slightly higher. The major movers in the sector included Baxter International Inc. (NYSE: BAX), CareFusion Corporation (NYSE: CFN), Unilife Corp. (NASDAQ: UNIS), and Mindray Medical International Ltd. (ADR) (NYSE: MR). AAAResearchReports.com initiated preliminary technical research on BAX, CFN, UNIS, and MR. These free reports are accessible by signing today at:
http://www.aaaresearchreports.com/register/
Shares in Baxter International Inc. ended lower on Friday. The company's shares oscillated between $69.23 and $70.00 before ending the day 0.62% lower at $69.27. A total of 3.92 million shares were traded which is above the daily average volume of 3.06 million. The company's shares fell 4.64% in the second quarter of 2013. The stock is currently trading below its 50-day moving average. Nonetheless, it is still trading above its 200-day moving average. The free technical analysis on BAX is available by signing up at:
http://www.AAAResearchReports.com/BAX070113.pdf
CareFusion Corporation's stock edged lower on Friday, finishing at $36.85, down 0.73% from its previous closing price. The company's shares fluctuated between $36.83 and $37.36. A total of 2.18 million shares were traded which is below the daily average volume of 2.46 million. Despite Friday's pullback, the company's shares have gained 0.11% in the last three trading sessions. Its shares are currently trading above their 50-day and 200-day moving averages. Register now to download free research on CFN at:
http://www.AAAResearchReports.com/CFN070113.pdf
Shares in Unilife Corp. rallied on Friday. The company's shares oscillated between $2.96 and $3.22 before finishing the day 4.97% higher at $3.17. A total of 1.35 million shares were traded which is slightly above the daily average volume of 1.31 million. The company's shares gained 8.56% last week, and 45.41% in the past three months, thus outperforming the S&P 500. A free report on UNIS can be accessed by registering at:
http://www.AAAResearchReports.com/UNIS070113.pdf
Mindray Medical International Ltd's stock moved lower on Friday, extending its losses from previous trading sessions. The company's shares fluctuated between $37.42 and $37.97 before closing the day 1.45% lower at $37.45. A total of 796,746 shares were traded which is slightly above the daily average volume of 766,276. The Mindray Medical's shares have fallen 2.47% in the last three trading sessions. Register with AAA Research Reports and download research on MR for free at:
http://www.AAAResearchReports.com/MR070113.pdf
----
EDITOR NOTES:
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected].
- For any urgent concerns or inquiries, please contact us at [email protected].
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to [email protected] for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
SOURCE AAA Research Reports
Share this article